Accountable for providing commercialization strategy and business case development for all pipeline assets in Biogen’s rare, neuromuscular disease franchise. Prepare commercial analysis and recommendations for critical program governance interactions with Executive Leadership to support advancement decisions.• Develop and manage product profiles, competitive intelligence, market landscapes, HCP/patient market research, and product forecasts; including revenue, patients, pricing and operating expenses.• Lead development of annual disease area strategic plan, ensuring alignment on cross-functional strategic goals that will drive growth over the next 5 years, including prioritized disease targets for research, BD targets for M&A, LCMs to enhance growth, and competitive strategies for franchise success.

Lead team of 5 responsible for forecasting Biogen’s entire in-line and late stage portfolio to enable long-term strategic decision-making and asset maximization. Therapy areas covered include Multiple Sclerosis, Alzheimer's Disease, Spinal Muscular Atrophy, ALS, Depression, Lupus, Stroke, and Movement Disorders. ▪ Deliver strategic analyses and recommendations for global brand teams and executives in support of billion-dollar decisions (e.g., indication expansions, growth opportunities, business deals, other LCMs) ▪ Lead annual long range forecasting process and executive presentations for Global Commercial organization (driving alignment around evidence-based assumptions, future risks and opportunities for the business) ▪ Build and continuously improve custom patient-based forecast models for each therapy area, including strategic market segments to quantify future growth opportunities and threats ▪ Lead Biogen's Forecasting Center of Excellence capability to support forecasting (patients, units, revenue) across Regions & Affiliates; Built affiliate forecasting ecosystem (template models, SharePoint repository, guidance documents) to drive alignment, accuracy, and cost efficiency across 50+ affiliate stakeholders ▪ Support BD assessments for external opportunities in existing Biogen therapy areas ▪ High performing team has earned 50+ awards for above-and-beyond service to stakeholders over my tenure

Strategic forecasting within Global Commercial Services -- providing strategic brand and therapeutic area decision support for Hemophilia, Spinal Muscular Atrophy, and Alzheimer's portfolios.

Responsible for US MS portfolio business insights, analytics and performance assessment. Led a team to utilize primary and secondary data and competitive intelligence to generate market insights, measure marketing impact, provide marketing strategy support, and manage brand performance tracking and explanation. Leveraged primary and secondary data, including IQVIA Xponent, specialty pharmacy patient longitudinal data feeds, as well as internal data to perform analysis to serve US Marketing and US Commercial Leadership Team.

Responsible for all launch analytics and insights for the Tecfidera marketing team and the US Commercial Leadership team.

Responsible for US commercial revenue and market share forecast for both Avonex, Tysabri and Tecfidera. Forecast used for annual budgets, Wall Street guidance, incentive compensation goals, manufacturing planning, and marketing / sales planning.

Lead data analyst on Tysabri supporting marketing, sales, and customer service as well as brand strategic planning.

Worked with top 10 pharmaceutical/biotech companies on more than two dozen strategy projects including product pricing and positioning, customer acquisition and retention, brand valuation, Medicare reform impact, portfolio R&D optimization, and loss of exclusivity strategy. In a high expectation, tight deadline environment, outperformed all other Associates to gain fastest promotions in company’s recent history and MVP award in 2005. Daily responsibilities include: ▪ Designing and executing primary research ▪ Managing primary/secondary data analysis ▪ Moderating interviews with HCPs, thought leaders, medical and pharmacy directors ▪ Parlaying findings into strategic recommendations ▪ Developing and giving client presentations ▪ Managing daily team priorities ▪ Writing new business proposals ▪ On-campus recruiting events for potential Associates/Consultants ▪ Mentoring Interns and Associates

As a member of the Wyeth Pharmaceuticals project team, used Excel, SQL, and Synygy EIM software to manage physician valuation and targeting, call plan compliance, and incentive compensation for a 5,000+ sales force. Worked directly with client to analyze trends in call effectiveness, evaluate changes and additions to incentive compensation plan, and determine valuation of territories for downsizing.